Acadian Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-33,721
| Closed | -$8.28M | – | 1968 |
|
|
2022
Q3 | $8.28M | Buy |
33,721
+27,504
| +442% | +$7.43M | 0.05% | 304 |
|
|
2022
Q2 | $1.54M | Buy |
6,217
+6,110
| +5,710% | +$1.65M | 0.01% | 698 |
|
|
2022
Q1 | $35K | Sell |
107
-1,148
| -91% | -$353K | ﹤0.01% | 1507 |
|
|
2021
Q4 | $448K | Sell |
1,255
-1,658
| -57% | -$560K | ﹤0.01% | 1038 |
|
|
2021
Q3 | $947K | Buy |
2,913
+115
| +4% | +$39K | ﹤0.01% | 863 |
|
|
2021
Q2 | $874K | Buy |
2,798
+1,210
| +76% | +$371K | ﹤0.01% | 968 |
|
|
2021
Q1 | $507K | Buy |
1,588
+75
| +5% | +$24K | ﹤0.01% | 1189 |
|
|
2020
Q4 | $491K | Buy |
1,513
+165
| +12% | +$45.6K | ﹤0.01% | 1237 |
|
|
2020
Q3 | $373K | Buy |
1,348
+655
| +95% | +$189K | ﹤0.01% | 1230 |
|
|
2020
Q2 | $168K | Buy |
+693
| New | +$139K | ﹤0.01% | 1554 |
|
|
2019
Q4 | – | Sell |
-2,316
| Closed | -$410K | – | 2121 |
|
|
2019
Q3 | $410K | Buy |
+2,316
| New | +$501K | ﹤0.01% | 1142 |
|
|
2019
Q2 | – | Sell |
-1,581
| Closed | -$451K | – | 2101 |
|
|
2019
Q1 | $451K | Sell |
1,581
-9,826
| -86% | -$3.27M | ﹤0.01% | 1119 |
|
|
2018
Q4 | $3.71M | Buy |
11,407
+2,567
| +29% | +$892K | 0.02% | 430 |
|
|
2018
Q3 | $3.98M | Sell |
8,840
-46,400
| -84% | -$18.3M | 0.02% | 417 |
|
|
2018
Q2 | $22.6M | Buy |
55,240
+55,210
| +184,033% | +$20M | 0.1% | 187 |
|
|
2018
Q1 | $9K | Buy |
+30
| New | +$7.6K | ﹤0.01% | 1561 |
|
|
2017
Q2 | – | Sell |
-56
| Closed | -$7K | – | 1652 |
|
|
2017
Q1 | $7K | Sell |
56
-16,327
| -100% | -$1.89M | ﹤0.01% | 1444 |
|
|
2016
Q4 | $1.85M | Sell |
16,383
-3,673
| -18% | -$426K | 0.01% | 608 |
|
|
2016
Q3 | $2.58M | Buy |
20,056
+19,937
| +16,754% | +$2.39M | 0.01% | 488 |
|
|
2016
Q2 | $13K | Buy |
119
+106
| +815% | +$10.5K | ﹤0.01% | 1188 |
|
|
2016
Q1 | $1K | Sell |
13
-58
| -82% | -$4.9K | ﹤0.01% | 1344 |
|
|
2015
Q4 | $6K | Buy |
+71
| New | +$6.03K | ﹤0.01% | 1292 |
|
|
2015
Q2 | – | Sell |
-287
| Closed | -$20K | – | 1536 |
|
|
2015
Q1 | $20K | Buy |
+287
| New | +$15.6K | ﹤0.01% | 1122 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Acadian Asset Management's ABMD Position: Q4 2022 in Review
Acadian Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 33,721 shares — an estimated $8.28M sold.
Acadian Asset Management first reported a position in ABMD in Q1 2015 and held it in 23 quarters. The position peaked at $22.6M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Acadian Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Acadian Asset Management sold 33,721 Abiomed Inc shares in Q4 2022, an estimated $8.28M.
- Acadian Asset Management first reported a position in Abiomed Inc in Q1 2015 and held it in 23 quarters.
- Acadian Asset Management's Abiomed Inc position peaked at $22.6M in Q2 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Acadian Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.